empagliflozin glp-1 How do SGLT-2 inhibitors, agonists, and DPP-4 inhibitors compare in reducing #mortality and #cardiovascular events in patients with type 2 #diabetes? Find out New GLP-1 Guidelines for Type

In the quest for optimal health, the spotlight is increasingly turning to metabolic balance

AstraZenecas deep pipeline of medicines focusing on their key therapeutic areas.

By fostering a relaxed state, this high Cortisol lowering supplement helps support overall well-being and a more refreshing, restorative experience

Numerous analysts have said the GLP-1s are very likely to disrupt certain areas of the MedTech industry, while others say MedTech can live side-by-side with the weight-loss drugs.1 In fact, the impact of GLP-1s is likely to be more nuanced than the blunt conclusions drawn by market watchers, with some companies and segments affected more than others

Weve been bugging the California Board of Pharmacy (politely!) for a while, trying to get a statement on its position and enforcement posture regarding the compounding of FDA-approved drugs that are currently in shortage